Inhibiting cadherin 11 significantly increases survival of mice with pancreatic cancer
Mice treated with a small molecule inhibitor of cadherin 11 (CDH11) had reduced pancreatic cancer growth and increased survival time.
List view / Grid view
Mice treated with a small molecule inhibitor of cadherin 11 (CDH11) had reduced pancreatic cancer growth and increased survival time.
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
The advent of immune checkpoint inhibitors is a major breakthrough in cancer immunotherapy...
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Ligands are useful tools for studying how proteins work in cells and could lead to the development of new drugs.